menu search

Leap therapeutics to present updated data from part a of the distinguish study of dkn-01 plus tislelizumab and chemotherapy in gastric cancer patients at the 2023 asco annual meeting

19.5 months median OS in the overall first-line patient population, exceeding current benchmarks Long-term follow-up identifies additional patient wit...

May 25, 2023, 5:10 pm

Nkgen announces poster presentation at the 2023 american society of clinical oncology (asco) annual meeting

SANTA ANA, Calif., May 25, 2023 (GLOBE NEWSWIRE) — NKGen biotech Inc. (“NKGen”), a clinical-stage...

May 25, 2023, 5:05 pm

Chimerix's trial treating pediatric brain tumors has a 'relatively high' chance of success

The biotechnology firm Chimerix has a high probability of success in its ongoing clinical trial in the treatment of pediatric brain tumors, according ...

May 25, 2023, 4:29 pm

Our acquisition of viatris business has been 'spooking the indian investor,' biotechnology firm says

Kiran Mazumdar-Shaw of Biocon & Biocon Biologics discusses the company's acquisition of Viatris' biosimilars business and says Indian investors are "v...

May 25, 2023, 1:11 am

3 biotech stocks with blockbuster potential

When it comes to possibilities of outsized rewards, few sectors can beat out biotech stocks with blockb...

May 24, 2023, 9:13 pm

Cytodyn announces president takes medical leave of absence

Antonio Migliarese assumes interim President roleDr. Melissa Palmer appointed interim Chief Medical OfficerDr. Salah Kivlighn joins CytoDyn as clinica...

May 24, 2023, 9:05 pm

Stevanato group to present at upcoming investor conferences

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost...

May 24, 2023, 4:01 pm

Novavax: sell the covid rips

Novavax, Inc. continues to rally on positive Covid news, but the vaccine demand continues to trend lower. The ...

May 24, 2023, 3:17 pm

Agilent technologies stock tumbles after it lowers outlook for its fiscal year

Agilent Technologies (NYSE:A) Inc stock tumbled after it cut its outlook for its fiscal year 2023 while noting that demand from ...

May 24, 2023, 12:42 pm

Ocugen, inc. announces pricing of $16.5 million public offering of common stock

MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercia...

May 24, 2023, 12:36 pm

Innovative cellular therapeutics (ict) presented data at the american society of gene and cell therapy (asgct) 26th annual meeting

ROCKVILLE, Md., May 24, 2023 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a co...

May 24, 2023, 12:00 pm

Jnana therapeutics announces milestone achieved under first collaboration with roche

Achievement of research milestone for immune program triggers milestone payment BOSTON, May 24, 2023 (GLOBE NEWSWIRE) — Jnana Therapeutics, a clinic...

May 24, 2023, 11:00 am

biotech stock drops on fda update

Sarepta Therapeutics Inc (NASDAQ:SRPT) is gaining some attention in the biotech realm today....

May 24, 2023, 10:53 am

Kineta set to join russell microcap® index

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...

May 24, 2023, 10:30 am

Pulmatrix selected to present at the annual biotechnology innovation organization (bio) international convention

Presentation will showcase Company's patented iSPERSE™ technology and positive topline results from Phase 1 study of PUR3100 for acute migraine LEXI...

May 24, 2023, 9:05 am

Nautilus biotechnology to participate in upcoming june investor conferences

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule prote...

May 24, 2023, 8:05 am

3 biotech stocks that could turn $1,000 into $10,000 by 2024

Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminat...

May 24, 2023, 8:00 am

Clover expands sales and distribution network for upcoming quadrivalent seasonal influenza vaccine launch in china

— Clover to leverage Kyuan Trade’s extensive sales and distribution network to complement in-house capabilities and maximize access to its quadriv...

May 23, 2023, 11:40 pm

Peter kolchinsky-led ra capital's new positions feature curevac, mineralys, pilant, enliven therapeu

The Boston-based fund has emerged as a force to be reckoned with in the world of biotech investments....

May 23, 2023, 10:32 pm

Assembly biosciences to present during the 2023 jefferies healthcare conference

SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovativ...

May 23, 2023, 8:05 pm


Search within

Pages Search Results: